Drug Type Prophylactic vaccine |
Synonyms- |
Target |
Action activators, agonists |
Mechanism NF-κB activators(Nuclear factor NF-kappa-B complex activators), TLR2 agonists(Toll like receptor 2 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Echinococcosis | Preclinical | China | 01 Oct 2025 | |
| Echinococcosis | Preclinical | China | 01 Oct 2025 |





